CrushSCI.com
111.4Average days
126Median days
55Fastest days
150Longest days
562025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

136 days

Understanding the phosphoantigen, butyrophilin, and γ9δ2 T cell axis

Authors
Yiming Jin; Sidra Bashir; Girija Pawge; Chia‐Hung Christine Hsiao; Andrew J. WiemerShow moreShow less
Affiliations
1. University of Connecticut; 2. Peking UniversityShow moreShow less
Source PDF DOI Publisher page
129 days

Ligand-of-Numb protein X1 controls the coxsackievirus B3-induced myocarditis via regulating the stability of coxsackievirus and adenovirus receptor

Authors
Ting Zhang; Changying Wang; Jinjuan Wei; Zhenyin Zhu; Xiaoni Wang; Chuang SunShow moreShow less
Affiliations
1. Department of Cardiology, XI’AN International Medical Center Hospital, Xi’an, ChinaShow moreShow less
Source PDF DOI Publisher page
55 days

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

Authors
Brecht Decraene; Yihan Yang; Frederik De Smet; Abhishek D. Garg; Patrizia Agostinis; Steven De VleeschouwerShow moreShow less
Affiliations
1. Research Group Experimental Neurosurgery and Neuroanatomy, Department of Neurosciences, KU Leuven, Leuven, Belgium; 2. Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium; 3. Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium; 4. Laboratory of Cell Death Research & Therapy, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium; 5. VIB Center for Cancer Biology Research, Leuven, Belgium; 6. Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium; 7. Leuven Brain Institute (LBI), KU Leuven, Leuven, BelgiumShow moreShow less
Source PDF DOI Publisher page
126 days

Mapping of novel loci involved in lung and colon tumor susceptibility by the use of genetically selected mouse strains

Authors
Andrea Borrego; José Ricardo Jensen; Wafa Hanna Koury Cabrera; Solange Massa; Orlando Garcia Ribeiro; Nancy Starobinas; Marcelo De Franco; Silas Fernandes Eto; Giacomo Manenti; Tommaso Antonio Dragani; Olga Martinez IbañezShow moreShow less
Affiliations
1. Laboratory of Immunogenetics, Instituto Butantan, São Paulo, Brazil; 2. Diagnostic section, Instituto Pasteur, São Paulo, Brazil; 3. Laboratory of Development and Innovation, Instituto Butantan, São Paulo, Brazil; 4. Genetic Epidemiology and Pharmacogenomics Unit Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, ItalyShow moreShow less
Source PDF DOI Publisher page
73 days

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients

Authors
Stefania Mantovani; Sergio Daga; Chiara Fallerini; Margherita Baldassarri; Elisa Benetti; Nicola Picchiotti; Francesca Fava; Anna Gallì; Silvia Zibellini; Mirella Bruttini; Maria Palmieri; Susanna Croci; Sara Amitrano; Diana Alaverdian; Katia Capitani; Simone Furini; Francesca Mari; Ilaria Meloni; Elisa Frullanti; Mario U. Mondelli; Alessandra RenieriShow moreShow less
Affiliations
1. Division of Clinical Immunology and Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 2. Medical Genetics, University of Siena, Siena, Italy; 3. Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy; 4. Department of Mathematics, University of Pavia, Pavia, Italy; 5. University of Siena, DIISM-SAILAB, Siena, Italy; 6. Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy; 7. Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy; 8. Core Research Laboratory, ISPRO, Florence, Italy; 9. Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, ItalyShow moreShow less
Source PDF DOI Publisher page
110 days

Association of genetic polymorphisms in IL-23R and IL-17A with the susceptibility to IgA nephropathy in a Chinese Han population

Authors
Hongyan Liao; Zhuochun Huang; Junlong Zhang; Bin YangShow moreShow less
Affiliations
1. Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, PR ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does GENES AND IMMUNITY take to review a manuscript?

As of 2026-11-19, CrushSCI has 11 complete review records for GENES AND IMMUNITY. The fastest paper went from submission to acceptance in 55 days (Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma, received 2021-11-05, accepted 2021-12-30); the slowest took 150 days. The average is 111.4 days and the median is 126 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.